Method of Administering a Therapeutic
AssigneeJuneau Biosciences, LLC
InventorKenneth Ward
Life of this patent
Estimating the term…
Abstract
The present invention relates to novel genetic markers associated with endometriosis and risk of developing endometriosis, and methods and materials for determining whether a human subject has endometriosis or is at risk of developing endometriosis and the use of such risk information in selectively administering a hormonal treatment such as a combined estrogen/progestin therapeutic which specifically includes an oral contraceptive that at least partially prevents or compensates for an endometriosis related symptom.
Claims68
A method of administering a therapeutic, said method comprising the following steps:
- assessing a predisposition for endometriosis in a subject that does not exhibit an endometriosis symptom, and
- administering a therapeutic to said subject.
A method of administering an oral contraceptive, said method comprising the following steps:
- assessing a predisposition for endometriosis in a subject that does not exhibit an endometriosis symptom, and
- administering an oral contraceptive to said subject.
A method of administering an ovulation suppression substance, said method comprising the following steps:
- assessing a predisposition for endometriosis in a subject that does not exhibit an endometriosis symptom, and
- administering an ovulation suppression substance to said subject.
A method of administering a therapeutic, said method comprising the following steps:
- detecting in the genetic material of said subject the presence of at least one genetic marker correlated with at least one endometriosis related condition,
- assessing a predisposition for endometriosis for said subject, and
- administering a therapeutic to said subject.
Dependencies are inferred from the claim text.